e8vk
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 3, 2010
GENOMIC HEALTH, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
(State or Other
Jurisdiction of
Incorporation)
|
|
000-51541
(Commission File Number)
|
|
77-0552594
(I.R.S. Employer
Identification No.) |
|
|
|
301 Penobscot Drive
Redwood City, California
(Address of principal executive offices)
|
|
94063
(Zip Code) |
(650) 556-9300
(Registrants telephone number,
including area code)
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligations of the registrant under any of the following provisions (see General Instruction
A.2. below):
|
|
|
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))
|
|
|
|
Item 2.02 |
|
Results of Operations and Financial Condition. |
On February 3, 2010, Genomic Health, Inc. issued a press release announcing financial results
for its fourth fiscal quarter and year ended December 31, 2009. The full text of the press release
is furnished as Exhibit 99.1.
The Companys 2010 Annual Meeting of Stockholders will be held on June 10, 2010 at such
place and time as will be set forth in the Companys proxy statement relating to that meeting. A
stockholder proposal not included in the proxy statement for the Companys 2010 Annual Meeting of
Stockholders will be ineligible for presentation at the meeting unless the stockholder gives timely
notice of the proposal in writing to the Secretary of the Company at the principal executive
offices of the Company and otherwise complies with the provisions of the Companys Bylaws. For the
2010 Annual Meeting of Stockholders, to be timely, the Companys Bylaws provide that the Secretary
of the Company must have received the stockholders notice not less than 90 days nor more than 120
days prior to the first anniversary date of the preceding years annual meeting. For the Companys
2010 Annual Meeting of Stockholders, stockholders must have submitted written notice to the
Secretary in accordance with the foregoing Bylaw provisions not earlier than February 8, 2010 nor
later than March 10, 2010.
|
|
|
Item 9.01 |
|
Financial Statements and Exhibits. |
(d) Exhibits
|
|
|
|
|
|
99.1 |
|
|
Press release issued by Genomic Health, Inc. dated February 3, 2010. |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: February 3, 2010
|
|
|
|
|
|
GENOMIC HEALTH, INC.
|
|
|
By: |
/s/ G. Bradley Cole
|
|
|
|
G. Bradley Cole |
|
|
|
Chief Operating Officer and Chief Financial Officer |
|
|
3
GENOMIC HEALTH, INC.
EXHIBIT INDEX
|
|
|
|
|
Exhibit |
|
|
Number |
|
Description |
|
99.1 |
|
|
Press release issued by Genomic Health, Inc. dated February 3, 2010 |
4